Rob Wagenvoord

3.8k citations

36 papers · 3.1k indexed · 2 hit papers · h-index 19

Hematology top 0.5%
Internal Medicine top 0.5%
Cardiology and Cardiovascular Medicine top 5%
Molecular Biology
Genetics top 2%

Co-authors: H.C. Hemker Suzette Beguı́n Peter Giesen Véronique Regnault Thomas Lecompte Raed Al Dieri A. Kemp Gillian M. Heaton
Topics: Blood Coagulation and Thrombosis Mechanisms (20 papers)Hemophilia Treatment and Research (8 papers)Blood properties and coagulation (7 papers)
Cited by: Internal Medicine Hematology Critical Care and Intensive Care Medicine
Journals: Blood The Journal of Immunology PLoS ONE
Partner nations: Netherlands France Sweden

In The Last Decade

Rob Wagenvoord

34 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Calibrated Automated Thrombin Generation Measurement in Clotting Plasma

2003 1.1k citations H.C. Hemker, Peter Giesen et al. Pathophysiology of Haemostasis and Thrombosis profile →
The Calibrated Automated Thrombogram (CAT): a universal routine test for hyper- and hypocoagulability

2002 517 citations H.C. Hemker, Peter Giesen et al. Pathophysiology of Haemostasis and Thrombosis profile →

Peers

Countries citing papers authored by Rob Wagenvoord

Since Specialization

Citations

This map shows the geographic impact of Rob Wagenvoord's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob Wagenvoord with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob Wagenvoord more than expected).

Fields of papers citing papers by Rob Wagenvoord

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rob Wagenvoord. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob Wagenvoord. The network helps show where Rob Wagenvoord may publish in the future.

Co-authorship network of co-authors of Rob Wagenvoord

This figure shows the co-authorship network connecting the top 25 collaborators of Rob Wagenvoord. A scholar is included among the top collaborators of Rob Wagenvoord based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rob Wagenvoord. Rob Wagenvoord is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Decreased prothrombin conversion and reduced thrombin inactivation explain rebalanced thrombin generation in liver cirrhosis 2017 ·PLoS ONE ·Romy Kremers,(unknown),Marisa Ninivaggi,Bas de Laat,Hugo Ten Cate,Ger H. Koek,Rob Wagenvoord,H.C. Hemker	33
2	A reduction of prothrombin conversion by cardiac surgery with cardiopulmonary bypass shifts the haemostatic balance towards bleeding 2016 ·Thrombosis and Haemostasis ·(unknown),Saartje Bloemen,Bas de Laat,Patrick W. Weerwind,B. Mochtar,Jos G. Maessen,Rob Wagenvoord,Raed Al Dieri,H.C. Hemker,(unknown)	16
3	The effect of fibrin(ogen) on thrombin generation and decay 2014 ·Thrombosis and Haemostasis ·Rob Wagenvoord,H.C. Hemker,(unknown)	34
4	A new regulatory function of activated factor V: inhibition of the activation by tissue factor/factor VII(a) of factor X 2013 ·Journal of Thrombosis and Haemostasis ·Raed Al Dieri,Saartje Bloemen,Hilde Kelchtermans,Rob Wagenvoord,H.C. Hemker	14
5	Fluorogenic Peptide‐Based Substrates for Monitoring Thrombin Activity 2012 ·ChemMedChem ·Sander S. van Berkel,(unknown),Floris L. van Delft,Rob Wagenvoord,H.C. Hemker,Floris P. J. T. Rutjes	17
6	The paradoxical stimulation by a reversible thrombin inhibitor of thrombin generation in plasma measured with thrombinography is caused by α2‐macroglobulin‐thrombin 2010 ·Journal of Thrombosis and Haemostasis ·Rob Wagenvoord,Johanna Deinum,Margareta Elg,H.C. Hemker	37
7	The technique of measuring thrombin generation with fluorogenic substrates: 3. The effects of sample dilution 2008 ·Thrombosis and Haemostasis ·Rob Wagenvoord,H.C. Hemker,(unknown)	32
8	Linear diffusion of thrombin and factor Xa along the heparin molecule explains the effects of extended heparin chain lengths 2007 ·Thrombosis Research ·Rob Wagenvoord,Raed Al Dieri,G. Van Dedem,Suzette Beguı́n,H.C. Hemker	13
9	Thrombin generation in mesalazine refractory ulcerative colitis and the influence of low molecular weight heparin 2007 ·Journal of Thrombosis and Thrombolysis ·Anton A. Vrij,(unknown),Gerard Dijkstra,Andrea E. van der Meulen‐de Jong,Rob Wagenvoord,H.C. Hemker,Reinhold W. Stockbrügger	9
10	The limits of simulation of the clotting system 2006 ·Journal of Thrombosis and Haemostasis ·Rob Wagenvoord,Piet Hemker,H.C. Hemker	42
11	Calibrated Automated Thrombin Generation Measurement in Clotting Plasmabreakdown → 2003 ·Pathophysiology of Haemostasis and Thrombosis ·H.C. Hemker,Peter Giesen,Raed Al Dieri,Véronique Regnault,(unknown),Rob Wagenvoord,Thomas Lecompte,Suzette Beguı́n	1150
12	Le domaine Choay — la structure responsable de l’activité anticoagulante des héparines 2003 ·Bulletin de l Académie Nationale de Médecine ·H.C. Hemker,Raed Al Dieri,Rob Wagenvoord,Suzette Beguı́n	2
13	The inhibition of blood coagulation by heparins of different molecular weight is caused by a common functional motif—the C-domain 2003 ·Journal of Thrombosis and Haemostasis ·Raed Al Dieri,Rob Wagenvoord,Gijs W. K. van Dedem,Suzette Beguı́n,H.C. Hemker	43
14	The Calibrated Automated Thrombogram (CAT): a universal routine test for hyper- and hypocoagulabilitybreakdown → 2002 ·Pathophysiology of Haemostasis and Thrombosis ·H.C. Hemker,Peter Giesen,(unknown),Véronique Regnault,(unknown),Rob Wagenvoord,Thomas Lecompte,Suzette Beguı́n	517
15	Binding of prothrombin and its fragment 1 to phospholipid membranes studied by the solvent relaxation technique 1998 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·Rudi Hutterer,F. W. Schneider,Wim Th. Hermens,Rob Wagenvoord,Martin Hof	29
16	Factor Xa Induces Cytokine Production and Expression of Adhesion Molecules by Human Umbilical Vein Endothelial Cells 1998 ·The Journal of Immunology ·Nicole H. M. Senden,T M Jeunhomme,Johan W. M. Heemskerk,Rob Wagenvoord,Cornelis van’t Veer,H.C. Hemker,Wim A. Buurman	150
17	Development of a Rapid and Sensitive Chromogenic Heparin Assay for Clinical Use 1993 ·Pathophysiology of Haemostasis and Thrombosis ·Rob Wagenvoord,(unknown),Hans-Jürgen Kolde,H.C. Hemker	8
18	Development of a Sensitive and Rapid Chromogenic Factor IX Assay for Clinical Use 1990 ·Pathophysiology of Haemostasis and Thrombosis ·Rob Wagenvoord,(unknown),Thuy Tran,H.C. Hemker	11
19	The number and localisation of adenine nucleotide-binding sites in beef-heart mitochondrial ATPase (F1) determined by photolabelling with 8-azido-ATP and 8-azido-ADP 1980 ·Biochimica et Biophysica Acta (BBA) - Bioenergetics ·Rob Wagenvoord,A. Kemp,E.C. Slater	54
20	The ATP‐ and ADP‐binding sites in mitochondrial coupling factor F₁ and their possible role in oxidative phosphorylation 1979 ·FEBS Letters ·E.C. Slater,A. Kemp,Ineke van der Kraan,Jans Muller,Oscar A. Roveri,G. J. Verschoor,Rob Wagenvoord,Jos P.M. Wielders	46

About Rob Wagenvoord

Rob Wagenvoord is a scholar working on Hematology, Internal Medicine and Critical Care and Intensive Care Medicine, having authored 36 papers that have together received 3.1k indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (20 papers), Hemophilia Treatment and Research (8 papers) and Blood properties and coagulation (7 papers). The work is most often cited by research in Internal Medicine (739 citations), Hematology (1.7k citations) and Critical Care and Intensive Care Medicine (218 citations). Rob Wagenvoord has collaborated with scholars based in Netherlands, France and Sweden. Frequent co-authors include H.C. Hemker, Suzette Beguı́n, Peter Giesen, Véronique Regnault, Thomas Lecompte, Raed Al Dieri, A. Kemp, Gillian M. Heaton, David G. Nicholls and Ineke van der Kraan. Their work appears in journals such as Blood, The Journal of Immunology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact